Design Therapeutics, Inc. (DSGN) shares outstanding

Shares outstanding · fiscal 2025
57.33M

Design Therapeutics, Inc. (DSGN) had 57.33M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.3% higher than the 56.59M of fiscal 2024. Figures as of 18 Nov 2026, 12:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
57.33M
Change on fiscal 2024
+1.3%
Highest on record
57.33Mfiscal 2025
Lowest on record
45.94Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Design Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 64.04M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 57.33M in fiscal 2025 and the lowest 45.94M in fiscal 2021.

History · 5 fiscal years

Shares outstanding by fiscal year

Design Therapeutics, Inc. shares outstanding, year by year

Design Therapeutics, Inc. (DSGN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202557.33M 1.3% up
202456.59M 1.1% up
202355.98M 0.5% up
202255.71M 21.3% up
202145.94M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on DSGN

Design Therapeutics, Inc., figure by figure

Design Therapeutics, Inc. (DSGN) overview: price, valuation and scorecard

Design Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Design Therapeutics, Inc. have?

Design Therapeutics, Inc. (DSGN) had 57.33M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.3% higher than the 56.59M of fiscal 2024. The market data feed counts 64.04M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Design Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 57.33M in fiscal 2025 and the lowest 45.94M in fiscal 2021.

How is Design Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Design Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Design Therapeutics, Inc. (DSGN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/DSGN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.